Experience With Letermovir Use For The Management Of Cytomegalovirus In Solid Organ Transplant Recipients.

被引：0
|
作者：
Orejas, J. L. [1 ]
Marty, F. M. [1 ]
McDonnell, A. M. [2 ]
Cheng, M. P. [1 ]
Arbona-Haddad, E. [1 ]
Hammond, S. P. [1 ]
Koo, S. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pharm, 75 Francis St, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A325
引用
收藏
页码：722 / 722
页数：1
相关论文
共 50 条
  • [1] Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients
    Razonable, Raymund R.
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 3987 - 4001
  • [2] Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients.
    Pereira, M. R.
    Aaron, J. G.
    Kubin, C. J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 459 - 460
  • [3] Letermovir treatment of cytomegalovirus infection or disease in solid organ and hematopoietic cell transplant recipients
    Linder, Kathleen A.
    Kovacs, Christopher
    Mullane, Kate M.
    Wolfe, Cameron
    Clark, Nina M.
    La Hoz, Ricardo M.
    Smith, Jeannina
    Kotton, Camille N.
    Limaye, Ajit P.
    Malinis, Maricar
    Hakki, Morgan
    Mishkin, Aaron
    Gonzalez, Arnoldo Adrian
    Prono, Maria Dioverti
    Ostrander, Darin
    Avery, Robin
    Kaul, Daniel R.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2021,
  • [4] Individualized management of cytomegalovirus in solid organ transplant recipients
    Saeed, Huma
    Thoendel, Matthew
    Razonable, Raymund R.
    [J]. EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2021, 6 (05): : 333 - 344
  • [5] Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients.
    Borges, L. F.
    Sparkman, T.
    Gutierrez, K.
    Banbury, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 988 - 988
  • [6] Leukemia in solid organ transplant recipients.
    Husted, TL
    Buell, JF
    Hanaway, MJ
    Thomas, MJ
    Woodle, ES
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 419 - 419
  • [7] Letermovir and Maribavir for the Treatment and Prevention of Cytomegalovirus Infection in Solid Organ and Stem Cell Transplant Recipients
    Imlay, Hannah N.
    Kaul, Daniel R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) : 156 - 160
  • [8] Letermovir as Step-Down Antiviral Treatment for Solid Organ Transplant Recipients with Cytomegalovirus Infection
    Codispodo, G. N.
    Lange, N. W.
    Burack, D.
    Salerno, D. M.
    Hedvat, J.
    Kovac, D.
    Pereira, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1116 - S1117
  • [9] Comparison of valganciclovir and oral ganciclovir for cytomegalovirus prophylaxis in solid organ transplant recipients.
    Kraman, AA
    Hardwick, LL
    Filo, RS
    Govani, MV
    Milgrom, ML
    Tector, AJ
    Pescovitz, MD
    [J]. PHARMACOTHERAPY, 2002, 22 (10): : 1370 - 1370
  • [10] Cytomegalovirus in Solid Organ Transplant Recipients
    Humar, A.
    Snydman, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : S78 - S86
12345